Sandra Zinkel
Department of Cell and Developmental Biology (CDB)
Program in Cancer Biology
Department of Medicine; Division of Hematology and Oncology
Vanderbilt-Ingram Cancer Center (VICC)
Vanderbilt Institute for Infection, Immunology and Inflammation (VI4)
We study the impact of programmed cell death and mitochondrial function on hematopoietic stem cell function and progression to bone marrow failure or leukemia. An additional focus is on identifying correlations between genetically regulated variations in gene expression and human blood disease.
Keywords: Programmed Cell Death , Blood cell development , Bone marrow failure/leukemia , BioVU/PrediXcan/genetically determined gene expression , inflammation , mitochondrial function
Research Area: Gene Regulation , Genomics , Cancer Biology , Molecular Pathology , Vascular Biology , Developmental Biology